Evidence map›Paper›PMID 34031587›Full record

ReviewNature reviews. Urology2021

Human kidney stones: a natural record of universal biomineralization.

Mayandi Sivaguru, Jessica J Saw, Elena M Wilson, John C Lieske, Amy E Krambeck, James C Williams, Michael F Romero, Kyle W Fouke, Matthew W Curtis, Jamie L Kear-Scott and 2 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Tartronic Acid as a Potential Inhibitor of Pathological Calcium Oxalate Crystallization.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Mayandi SivaguruCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA. sivaguru@illinois.edu.ORCID http://orcid.org/0000-0001-5532-4393
Jessica J SawCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
Elena M WilsonCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
John C LieskeDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-0202-5944
Amy E KrambeckDepartment of Urology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-8255-598X
James C WilliamsDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0001-6665-6596
Michael F RomeroDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0002-1555-7835
Kyle W FoukeJackson School of Geosciences, University of Texas at Austin, Austin, TX, USA.
Matthew W CurtisCarl Zeiss Microscopy LLC, One North Broadway, White Plains, NY, USA.ORCID http://orcid.org/0000-0002-1516-1531
Jamie L Kear-ScottCarl Zeiss Microscopy LLC, One North Broadway, White Plains, NY, USA.
Nicholas ChiaDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0001-9652-691X
Bruce W FoukeCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL, USA. fouke@illinois.edu.ORCID http://orcid.org/0000-0001-7698-7241
Mayo Clinic · USCarle Foundation Hospital · USCarl Zeiss (United States) · USUniversity of Illinois Urbana-Champaign · USIndiana University School of MedicineMayo Clinic in Arizona · USThe University of Texas at Austin · US

Funding

VISUALIZATION AND PATHOPHYSIOLOGY OF RENAL STONE PRECURSOR LESIONSU54DK100227 · NIDDK · MAYO CLINIC ROCHESTER · PI LIESKE, JOHN C · 2013 to 2017
$6.3M
NASA NNA13AA93ANIDDK NIH HHS U54 DK100227
6 · The paper itself

Abstract

GeoBioMed - a new transdisciplinary approach that integrates the fields of geology, biology and medicine - reveals that kidney stones composed of calcium-rich minerals precipitate from a continuum of repeated events of crystallization, dissolution and recrystallization that result from the same fundamental natural processes that have governed billions of years of biomineralization on Earth. This contextual change in our understanding of renal stone formation opens fundamentally new avenues of human kidney stone investigation that include analyses of crystalline structure and stratigraphy, diagenetic phase transitions, and paragenetic sequences across broad length scales from hundreds of nanometres to centimetres (five Powers of 10). This paradigm shift has also enabled the development of a new kidney stone classification scheme according to thermodynamic energetics and crystalline architecture. Evidence suggests that ≥50% of the total volume of individual stones have undergone repeated in vivo dissolution and recrystallization. Amorphous calcium phosphate and hydroxyapatite spherules coalesce to form planar concentric zoning and sector zones that indicate disequilibrium precipitation. In addition, calcium oxalate dihydrate and calcium oxalate monohydrate crystal aggregates exhibit high-frequency organic-matter-rich and mineral-rich nanolayering that is orders of magnitude higher than layering observed in analogous coral reef, Roman aqueduct, cave, deep subsurface and hot-spring deposits. This higher frequency nanolayering represents the unique microenvironment of the kidney in which potent crystallization promoters and inhibitors are working in opposition. These GeoBioMed insights identify previously unexplored strategies for development and testing of new clinical therapies for the prevention and treatment of kidney stones.

Indexed as

ApatitesBiomineralizationCalcium OxalateCalcium PhosphatesCrystallizationDurapatiteGeological PhenomenaHumansKidney CalculiNephrolithiasisPhase Transitionamorphous calcium phosphateApatitesCalcium OxalateCalcium PhosphatesDurapatite

Identifiers

PMID34031587
OpenAlexW3165774818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.